All In MedTech

FDA Clearance Tracker · P150017-S015

Cartiva Synthetic Cartilage Implant (SCI)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 10, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 10, 2021

Approved

Time to decision

163 days

Received Jun 30, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150017-S015
Device name
Cartiva Synthetic Cartilage Implant (SCI)
Applicant
Cartiva, Inc.
Applicant location
Alpharetta, GA
Received
Jun 30, 2021
Decided
Dec 10, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150017

Device type

Device class
Class III

Every decision under product code PNW

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Building C, 11576 Memphis-Arlington Road, Arlington, Tennessee 38002 as a secondary manufacturing and packaging site of Cartiva SCI devices.

Source documents

Other decisions for Cartiva, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.